Form 4 for KLRS Kalaris Therapeutics, Inc.
Accepted 2023-06-28 00:00:00 ET · period of report 2023-06-27 · accession 0001062993-23-014111 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-28 | 2023-06-27 | KLRS | GILEAD SCIENCES, INC. | 10% | P - Purchase | $3.75 | +2.93M | 16.64M | +21% | +$10.99M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-27 | P | A | 2,930,870 | $3.75 | 16,635,286 | D | — | — |